uniQure N.V. (QURE) stock analysis and AI prediction
The company facts of uniQure N.V., with its price and AI prediction for the next 10 market days in SharePreds.
Keep looking in SharePreds
You have looked at today's stocks on this website. SharePreds shows every stock's likelihood of rising, its chart and how its earlier predictions ended, with alerts on the ones you follow.
See all five apps
About uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
- Sector
- Healthcare
- Exchange
- NASDAQ
- Market value
- $1.7 billion
- Size
- Small cap
- Employees
- 221
- Headquarters
- AMSTERDAM
- Listed since
- Feb. 5, 2014
- Website
- uniqure.com
More Healthcare stocks
Other small cap stocks
Keep going
QURE questions
What is the AI prediction for QURE stock?
Each market day our model rates uniQure N.V. (QURE) Bullish, Neutral or Bearish for the next 10 market days. Predictions are indicative: they rest on price and volume data, and they can be wrong.
How often is the QURE prediction updated?
Each market day, Monday to Friday, except market holidays. The date of the prediction is shown beside it.
What do Bullish, Neutral and Bearish mean?
Bullish means the model sees a rise as likely over the next 10 market days, Bearish a fall, and Neutral no clear direction.
Where can I see the exact likelihood for QURE?
In the SharePreds app for iPhone and Android, with the stock's chart, alerts on it and how its earlier predictions ended.
Where can I see QURE options?
The QURE options page opens its calls and puts, with price, volume, implied volatility and the Greeks.